A group of pediatricians and public health officials petitioned the FDA to ban marketing cold remedies like Toddler's Dimetapp to children under 6.
They acknowledged the safety of these medicines but warned of common overdoses due to multiple medications.
The FDA highlighted insufficient testing of children's cold medicines, with some cases leading to medical problems.
Johnson & Johnson recalled infant products after FDA warnings, while CVS removed affected items.
The FDA urged caution in giving cough and cold medicines to children under 2, emphasizing proper dosing and consulting healthcare providers.
The industry voluntarily withdrew infant cough and cold medicines amid safety concerns, with calls for a ban on such products
